Reynders McVeigh Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-700
| Closed | -$264K | – | 232 |
|
|
2021
Q4 | $264K | Sell |
700
-50
| -7% | -$18.9K | 0.02% | 206 |
|
|
2021
Q3 | $310K | Sell |
750
-125
| -14% | -$51.7K | 0.02% | 187 |
|
|
2021
Q2 | $324K | Sell |
875
-75
| -8% | -$27.8K | 0.02% | 189 |
|
|
2021
Q1 | $275K | Sell |
950
-150
| -14% | -$43.4K | 0.02% | 199 |
|
|
2020
Q4 | $275K | Buy |
+1,100
| New | +$275K | 0.02% | 194 |
|